1998
DOI: 10.1016/s0168-1656(98)00143-6
|View full text |Cite
|
Sign up to set email alerts
|

The conformation of purified Toxoplasma gondii SAG1 antigen, secreted from engineered Pichia pastoris, is adequate for serorecognition and cell proliferation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

3
26
0

Year Published

2000
2000
2015
2015

Publication Types

Select...
10

Relationship

2
8

Authors

Journals

citations
Cited by 39 publications
(29 citation statements)
references
References 29 publications
3
26
0
Order By: Relevance
“…In addition, these proteins do not contain contaminants derived from the bacterial cells and, therefore, do not give cross-reactions with human sera. In recent years, the Pichia expression system in particular has been used successfully to produced numerous T. gondii recombinant antigens (22,24,75,(80)(81)(82)(83). Thus, there is a need to obtain the new recombinant antigens in different eukaryotic expression systems.…”
Section: Resultsmentioning
confidence: 99%
“…In addition, these proteins do not contain contaminants derived from the bacterial cells and, therefore, do not give cross-reactions with human sera. In recent years, the Pichia expression system in particular has been used successfully to produced numerous T. gondii recombinant antigens (22,24,75,(80)(81)(82)(83). Thus, there is a need to obtain the new recombinant antigens in different eukaryotic expression systems.…”
Section: Resultsmentioning
confidence: 99%
“…Animals infected with N. caninum reacted strongly to Ncp29 while those infected with T. gondii showed negative ELISA titers. Proteins Ncp29 and SAG1 (also known as p30) from T. gondii have approximately 50% identity at the amino acid level, and both contain 12 cysteine residues that are predicted to be involved in the conformational folding of the protein, a property that is likely important for the highly antigenic nature of SAG1 (5,7,24). Following infection with T. gondii, antibodies to SAG1 appear very early and include immunoglobulin M (IgM) and IgA, as well as IgG classes (10,34), making this Table 1.…”
Section: Resultsmentioning
confidence: 99%
“…An effective vaccine against human T. gondii infection is desirable, and SAG1 is one of the most promising vaccine candidates (4,10,26). However, toxoplasmosis is also problematic in an immunocompromised host, and passive immunization may be useful in such a host due to reduced cellular immunity.…”
Section: Discussionmentioning
confidence: 99%